Kinetin riboside [4338-47-0]
Cat# T7337-25mg
Size : 25mg
Marca : TargetMol
Select Batch
Purity:99.82%
Appearance:Solid
Color:White
COA HNMR LCMS
Product Introduction
Bioactivity
Chemical Properties
Storage & Solubility Information
| Description | Kinetin riboside (N6-Furfuryladenosine) can induce apoptosis in cancer cells. It inhibits the proliferation of HCT-15 cells(IC50 of 2.5 μM) |
| Targets&IC50 | HCT15 cells:2.5 μM |
| In vitro | kinetin riboside displays antiproliferative and apoptogenic activity against various human cancer cell lines and has been shown to suppress tumor growth in murine xenograft models of human leukemia and melanoma[1]. |
| Synonyms | N6-Furfuryladenosine |
| Molecular Weight | 347.33 |
| Formula | C15H17N5O5 |
| Cas No. | 4338-47-0 |
| Smiles | OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n1cnc2c(NCc3ccco3)ncnc12 |
| Relative Density. | 1.78g/cm3 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | ||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 29 mg/mL (83.49 mM), Sonication is recommended. | ||||||||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 2 mg/mL (5.76 mM), Sonication is recommended. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | ||||||||||||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||||||||||||
DMSO
Note : The dilution table applies only to solid products. For liquid products, please calculate the stock solution based on the stated concentration and/or density. | |||||||||||||||||||||||||||||||


